Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

MRI phenotypes in MS: Longitudinal changes and miRNA signatures.

Hemond CC, Healy BC, Tauhid S, Mazzola MA, Quintana FJ, Gandhi R, Weiner HL, Bakshi R.

Neurol Neuroimmunol Neuroinflamm. 2019 Feb 14;6(2):e530. doi: 10.1212/NXI.0000000000000530. eCollection 2019 Mar.

2.

Differences in Intercellular Communication During Clinical Relapse and Gadolinium-Enhanced MRI in Patients With Relapsing Remitting Multiple Sclerosis: A Study of the Composition of Extracellular Vesicles in Cerebrospinal Fluid.

Geraci F, Ragonese P, Barreca MM, Aliotta E, Mazzola MA, Realmuto S, Vazzoler G, Savettieri G, Sconzo G, Salemi G.

Front Cell Neurosci. 2018 Nov 15;12:418. doi: 10.3389/fncel.2018.00418. eCollection 2018.

3.

Identification of MS-specific serum miRNAs in an international multicenter study.

Regev K, Healy BC, Paul A, Diaz-Cruz C, Mazzola MA, Raheja R, Glanz BI, Kivisäkk P, Chitnis T, Jagodic M, Piehl F, Olsson T, Khademi M, Hauser S, Oksenberg J, Khoury SJ, Weiner HL, Gandhi R.

Neurol Neuroimmunol Neuroinflamm. 2018 Aug 20;5(5):e491. doi: 10.1212/NXI.0000000000000491. eCollection 2018 Sep.

4.

Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis.

Raheja R, Regev K, Healy BC, Mazzola MA, Beynon V, Von Glehn F, Paul A, Diaz-Cruz C, Gholipour T, Glanz BI, Kivisakk P, Chitnis T, Weiner HL, Berry JD, Gandhi R.

Muscle Nerve. 2018 Aug;58(2):261-269. doi: 10.1002/mus.26106. Epub 2018 Mar 25.

5.

Monomethyl fumarate treatment impairs maturation of human myeloid dendritic cells and their ability to activate T cells.

Mazzola MA, Raheja R, Regev K, Beynon V, von Glehn F, Paul A, Pierre I, Kivisakk P, Weiner HL, Gandhi R.

Mult Scler. 2019 Jan;25(1):63-71. doi: 10.1177/1352458517740213. Epub 2017 Nov 6.

PMID:
29106333
6.

Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: a cohort study.

Ragonese P, Aridon P, Vazzoler G, Mazzola MA, Lo Re V, Lo Re M, Realmuto S, Alessi S, D'Amelio M, Savettieri G, Salemi G.

BMC Neurol. 2017 Aug 8;17(1):155. doi: 10.1186/s12883-017-0932-0.

7.

Targeting latency-associated peptide promotes antitumor immunity.

Gabriely G, da Cunha AP, Rezende RM, Kenyon B, Madi A, Vandeventer T, Skillin N, Rubino S, Garo L, Mazzola MA, Kolypetri P, Lanser AJ, Moreira T, Faria AMC, Lassmann H, Kuchroo V, Murugaiyan G, Weiner HL.

Sci Immunol. 2017 May 19;2(11). pii: eaaj1738. doi: 10.1126/sciimmunol.aaj1738.

8.

Dynamic regulation of serum aryl hydrocarbon receptor agonists in MS.

Rothhammer V, Borucki DM, Garcia Sanchez MI, Mazzola MA, Hemond CC, Regev K, Paul A, Kivisäkk P, Bakshi R, Izquierdo G, Weiner HL, Quintana FJ.

Neurol Neuroimmunol Neuroinflamm. 2017 Jun 16;4(4):e359. doi: 10.1212/NXI.0000000000000359. eCollection 2017 Jul.

9.

Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.

Regev K, Healy BC, Khalid F, Paul A, Chu R, Tauhid S, Tummala S, Diaz-Cruz C, Raheja R, Mazzola MA, von Glehn F, Kivisakk P, Dupuy SL, Kim G, Chitnis T, Weiner HL, Gandhi R, Bakshi R.

JAMA Neurol. 2017 Mar 1;74(3):275-285. doi: 10.1001/jamaneurol.2016.5197.

10.

Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis.

Regev K, Paul A, Healy B, von Glenn F, Diaz-Cruz C, Gholipour T, Mazzola MA, Raheja R, Nejad P, Glanz BI, Kivisakk P, Chitnis T, Weiner HL, Gandhi R.

Neurol Neuroimmunol Neuroinflamm. 2016 Aug 23;3(5):e267. doi: 10.1212/NXI.0000000000000267. eCollection 2016 Oct. Erratum in: Neurol Neuroimmunol Neuroinflamm. 2016 Oct 07;3(6):e296.

11.

Alterations of the human gut microbiome in multiple sclerosis.

Jangi S, Gandhi R, Cox LM, Li N, von Glehn F, Yan R, Patel B, Mazzola MA, Liu S, Glanz BL, Cook S, Tankou S, Stuart F, Melo K, Nejad P, Smith K, Topçuolu BD, Holden J, Kivisäkk P, Chitnis T, De Jager PL, Quintana FJ, Gerber GK, Bry L, Weiner HL.

Nat Commun. 2016 Jun 28;7:12015. doi: 10.1038/ncomms12015.

12.

Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation.

Mazzola MA, Raheja R, Murugaiyan G, Rajabi H, Kumar D, Pertel T, Regev K, Griffin R, Aly L, Kivisakk P, Nejad P, Patel B, Gwanyalla N, Hei H, Glanz B, Chitnis T, Weiner HL, Gandhi R.

J Neuroinflammation. 2015 Dec 30;12:245. doi: 10.1186/s12974-015-0460-z.

13.

Identification of biomarkers in cerebrospinal fluid and serum of multiple sclerosis patients by immunoproteomics approach.

Colomba P, Fontana S, Salemi G, Barranca M, Lo Sicco C, Mazzola MA, Ragonese P, Savettieri G, De Leo G, Alessandro R, Duro G.

Int J Mol Sci. 2014 Dec 15;15(12):23269-82. doi: 10.3390/ijms151223269.

14.

Frontal dementia related to thalamic stroke: a case report.

Realmuto S, Arnao V, Cinturino A, Mazzola MA, Talamanca S, Riolo M, Cusmano I, Cupidi C, Piccoli T.

Neurol Sci. 2013 Jun;34(6):999-1001. doi: 10.1007/s10072-012-1146-2. Epub 2012 Jul 5. No abstract available.

PMID:
22763582
15.

Tumor diagnosis preceding Alzheimer's disease onset: is there a link between cancer and Alzheimer's disease?

Realmuto S, Cinturino A, Arnao V, Mazzola MA, Cupidi C, Aridon P, Ragonese P, Savettieri G, D'Amelio M.

J Alzheimers Dis. 2012;31(1):177-82. doi: 10.3233/JAD-2012-120184.

PMID:
22531415
16.

Reversible posterior leukoencephalopathy syndrome in a patient with thrombotic thrombocytopenic purpura.

Aridon P, Ragonese P, Mazzola MA, Quintini G, Lo Re M, Talamanca S, Terruso V, D'Amelio M, Savettieri G.

Neurol Sci. 2011 Jun;32(3):469-72. doi: 10.1007/s10072-010-0465-4. Epub 2011 Jan 14.

PMID:
21234778
17.

Multiple sclerosis survival: a population-based study in Sicily.

Ragonese P, Aridon P, Mazzola MA, Callari G, Palmeri B, Famoso G, Terruso V, Salemi G, D'Amelio M, Savettieri G.

Eur J Neurol. 2010 Mar;17(3):391-7. doi: 10.1111/j.1468-1331.2009.02814.x. Epub 2009 Oct 23.

PMID:
19863646
18.

Leprosy: report of a case with severe peripheral neuropathy.

Aridon P, Ragonese P, Mazzola MA, Terruso V, Palermo A, D'Amelio M, Savettieri G.

Neurol Sci. 2010 Feb;31(1):75-7. doi: 10.1007/s10072-009-0152-5. Epub 2009 Oct 8.

PMID:
19812892
19.

Frequency and determinants for hemorrhagic transformation of cerebral infarction.

Terruso V, D'Amelio M, Di Benedetto N, Lupo I, Saia V, Famoso G, Mazzola MA, Aridon P, Sarno C, Ragonese P, Savettieri G.

Neuroepidemiology. 2009;33(3):261-5. doi: 10.1159/000229781. Epub 2009 Jul 27.

PMID:
19641332
20.

Body mass index does not change before Parkinson's disease onset.

Ragonese P, D'Amelio M, Callari G, Di Benedetto N, Palmeri B, Mazzola MA, Terruso V, Salemi G, Savettieri G, Aridon P.

Eur J Neurol. 2008 Sep;15(9):965-8. doi: 10.1111/j.1468-1331.2008.02236.x. Epub 2008 Jul 14.

PMID:
18637822

Supplemental Content

Loading ...
Support Center